However, an extremely high prevalence of hyperglycaemia requiring insulin treatment was seen in the high-dose corticosteroid group (5.0% [no-corticosteroid] vs 21.7% [high-dose corticosteroid], p = 0.0002). The gene discussed is INS; the disease is Hyperglycemia.